JPH031021B2 - - Google Patents

Info

Publication number
JPH031021B2
JPH031021B2 JP61315582A JP31558286A JPH031021B2 JP H031021 B2 JPH031021 B2 JP H031021B2 JP 61315582 A JP61315582 A JP 61315582A JP 31558286 A JP31558286 A JP 31558286A JP H031021 B2 JPH031021 B2 JP H031021B2
Authority
JP
Japan
Prior art keywords
medical article
packaging
package
heat
layer made
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61315582A
Other languages
Japanese (ja)
Other versions
JPS63164950A (en
Inventor
Tatsuhiko Kawaoka
Nakao Matsunaga
Hironori Imoto
Sunao Tsukamoto
Ryuichi Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Toppan Inc
Original Assignee
Terumo Corp
Toppan Printing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp, Toppan Printing Co Ltd filed Critical Terumo Corp
Priority to JP61315582A priority Critical patent/JPS63164950A/en
Publication of JPS63164950A publication Critical patent/JPS63164950A/en
Publication of JPH031021B2 publication Critical patent/JPH031021B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】[Detailed description of the invention]

[産業上の利用分野] この発明は、医療用物品包装体および包装材料
に関する。 [従来の技術] 従来、アミノ酸製剤、脂肪乳剤、ビタミン製剤
等の薬液は、これを柔軟なプラスチツツク容器に
収容し、オートクレーブ滅菌されて提供されてい
る。しかしながら、これら薬液は酸素によつて変
質しやすく、滅菌時や保管時に容器壁を通り抜
け、薬液に溶け込んだ酸素によつて変質してしま
うという問題があつた。 そのため、上記薬液を収容するプラスチツク製
容器をガスバリヤー性の高い包材でより包装する
ことがおこなわれている。しかしながら、従来使
用されているガスバリヤー性包材は、耐熱性が低
く、滅菌時の熱によつて変形してしまう。したが
つて、上記容器をまず耐熱性を有する包材で包装
し、これをオートクレーブ滅菌した後、ガスバリ
ヤー性包材で再度包装するという二重包装をおこ
なつている。しかしながら、ガスバリヤー性包材
は、上記のように、耐熱性に劣るばかりでなく、
耐衝撃性にも劣り、輸送中の衝撃でピンホールが
生じやすく、このピンホールから酸素が侵入し、
薬液を変質させるという問題がある。 [発明が解決しようとする問題点] 上に見たように、従来では、液体特に薬液を収
容する医療用物品を二重包装してもオートクレー
ム滅菌時の耐熱性、ガスバリヤー性および耐衝撃
性を全て同時に満足させることはできていない。 したがつて、この発明は、一重包装でしかもオ
ートクレーブ滅菌時の耐熱性、ガスバリヤー性、
および耐衝撃性を同時に満足できる医療用物品包
装体および包装材料を提供することを目的とす
る。 [問題点を解決するための手段] この発明では、液体特に薬液を収容する医療用
物品を包装する包装体あるいは包装材料として、
耐熱性を有し熱シール性を有する内層と、121℃
における熱収縮率が4%末満である芳香族系ポリ
アミド樹脂からなる中間層と、該内層よりも高い
融点を有する外層との積層体からなり、オートク
レーブ滅菌後において平均で4.8c.c./m2・気圧・
20℃・65%相対湿度以下の酸素透過度を有するも
のを用いている。 上記外層は、塩化ビニリデン樹脂をコートした
ポリステルフイルムからなり、中間層は、二軸延
伸芳香族ナイロンフイルムからなり、また内層
は、未延伸ポリプロピレンフイルムからなる。 [実施例] 以下、この発明を添付図面を参照してより具体
的に説明する。 第1図に示すように、液体を収容した医療用物
品特に薬液13入りプラスチツク製容器11は、
この発明の包装材料からなる包装体14に包装さ
れている。 容器11はポリ塩化ビニル樹脂、架橋されたエ
チレン−酢酸ビニル共重合体等柔軟なプラスチツ
クで形成されている。容器11の一端部には容器
11内と連通するポート12が設けられ、例えば
酸素によつて変質しやすい成分を含む薬液13特
にトリプトフアンを含む高濃度(10〜12重量%)
アミノ酸輸液剤、脂肪乳剤、ビタミン製剤等がポ
ート12から容器11内に導入されている。薬液
13を容器11内に導入した後、ポート12は高
周波融着等により適当なシール部材で密封され
る。 薬液入りプラスチツク製容器11は、包装体1
4に真空包装されていることが好ましい。真空包
装することにより、包装体14と容器11との間
に存在する酸素量を最小限にすることができ、薬
液13中への酸素侵入を防止することができると
ともに、空気相がほとんど存在しなくなるので熱
伝導性が向上する結果、オートクレーブ滅菌が効
率よくおこなえる。 薬液入りプラスチツク製容器11を包装する包
装体14は、薬液の状態を目視することから透明
なものであることが好ましく、第2図に示すよう
に、内層21と中間層22と外層23との積層体
からなる。内層21は、以後述べるオートクレー
ブ滅菌時の熱に耐え得る耐熱性(変形しない)を
有するとともに、熱シールをすることから熱シー
ル性を有するものである。また、この内層21
は、耐透湿性も良好であることが好ましい。この
ような内層21を構成するプラスチツク材料とし
ては、未延伸ポリプロピレンが特に好ましい。内
層材料としては高密度ポリエチレンも考えられる
が、透明性に難点がある。なお内層21は、60〜
80μmの厚さを有することが好ましい。 中間層22は、121℃における熱収縮率(121℃
x30分間、飽和水蒸気中)が4%未満の二軸延伸
芳香族ナイロンフイルムからなる。熱収縮率が4
%を越えると、内層21、外層23の剥離やしわ
が生じてしまう。また透明性も低下する。この中
間層22はガス(特に酸素ガス)バリヤー性も良
好であるとともに、機械的強度、耐透湿性も優れ
ていることが好ましい。中間層22を構成する材
料としては二軸延伸ナイロンフイルムが特に好ま
しい。なお、ガスバリヤー性の優れた材料とし
て、二軸延伸芳香族ナイロンフイルム以外に塩化
ビニリデン樹脂、エチレンー酢酸ビニル共重合体
ケン化物等もあるが、耐熱性、耐水性に劣るた
め、中間層22としては、不適当である。なお、
中間層22は、10〜20μmの厚さを有することが
好ましい。 外層23は、オートクレーブ滅菌時の熱の影響
を最も受け易い部分であり、内層21よりも高い
融点を持つことが必要である。また、外層23
は、ガスバリヤー性および耐透湿性も良好である
ことが望ましい。このような外層23を構成する
プラスチツク材料としては、塩化ビニリデン樹脂
を内面に1〜3μmの厚さにコート(いわゆるK
コート)したポリエステルフイルムが特に好まし
い。なお、外層23は7〜17μmの厚さを有する
ことが好ましい。 包装体14は周縁部14aにおいて、内層同志
が熱シールされている(第1図)。 こうして、包装体14で包装された薬液入りプ
ラスチツク製容器11は、包装体14で包装され
たままで、実質的に酸素の存在しない飽和水蒸気
からなる雰囲気中で高圧蒸気滅菌される。高圧蒸
気滅菌(オートクレーブ滅菌)は、通常121℃で
20分〜30分間おこなわれる。このとき、包装体1
4は、その透明性がほとんど低下せず、しかもガ
スバリヤー性の低下も少ない。包装体14は、こ
のようなオートクレーブ滅菌後においても、JIS
規格で全体の平均で4.8c.c./m2・気圧・24時間・
気圧・20℃・65%相対湿度以下好ましくは3.0
c.c./m2・24時間・気圧・20℃・65%相対湿度以下
より好ましくは2.5c.c./m2・24時間・気圧・20
℃・65%相対湿度以下の酸素透過度を有するもの
である。 以下、この発明に係る医療用物品包装体に関す
る振動試験、着色レベル試験、ヘツドスペース酸
素濃度試験、溶存酸素濃度試験、薬液のPH試験、
トリプトフアン含量試験の結果を比較例のそれと
ともに示す。 振動試験 薬液としてトリプトフアンを含むアミノ酸製剤
を収容したプラスチツク製容器をそれぞれ以下の
構成の包装材料で包装した。 本発明…内層:厚さ70μmの未延伸ポリプロピレ
ンフイルム 中間層:厚さ15μmの二軸延伸ナイロン
フイルム 外層:Kコート(厚さ1〜3μm)した厚
さ12μmのポリエステルフイルム 比較例…内層:厚さ60μmのポリエチレンフイル
ム 中間層:厚さ15μmのポリ塩化ビニリデ
ンフイルム 外層:厚さ15μmのナイロンフイルム 上記各試料を包装貨物振動試験機でJISZ0232
振動試験法に基づき、5Gx1時間の振動試験をお
こない、包装材料におけるピンホールの発生を観
察した。各試料20個につきピンホールが発生した
試料数を以下の表1に示す。
[Industrial Application Field] The present invention relates to a medical article package and a packaging material. [Prior Art] Conventionally, medicinal solutions such as amino acid preparations, fat emulsions, and vitamin preparations have been stored in flexible plastic containers and sterilized by autoclaving. However, these chemical liquids are easily deteriorated by oxygen, and there is a problem in that during sterilization or storage, the chemical liquid passes through the container wall and is deteriorated by the oxygen dissolved in the chemical liquid. Therefore, plastic containers containing the above-mentioned chemical solutions are now being packaged with packaging materials having high gas barrier properties. However, conventionally used gas barrier packaging materials have low heat resistance and are deformed by heat during sterilization. Therefore, double packaging is performed in which the container is first wrapped in a heat-resistant packaging material, then sterilized in an autoclave, and then wrapped again in a gas barrier packaging material. However, as mentioned above, gas barrier packaging materials not only have poor heat resistance, but also
It also has poor impact resistance, and pinholes are likely to form due to impact during transportation, and oxygen can enter through these pinholes.
There is a problem of deteriorating the chemical liquid. [Problems to be Solved by the Invention] As seen above, conventionally, even if medical articles containing liquids, especially medical solutions, are double-packaged, the heat resistance, gas barrier properties, and impact resistance during autoclaim sterilization are insufficient. It is not possible to satisfy all sexual needs at the same time. Therefore, the present invention provides heat resistance, gas barrier properties, and
It is an object of the present invention to provide a medical article packaging body and packaging material that can simultaneously satisfy the requirements of impact resistance and impact resistance. [Means for Solving the Problems] In the present invention, as a packaging body or packaging material for packaging a medical article containing a liquid, particularly a medical solution,
Inner layer with heat resistance and heat sealability, 121℃
It consists of a laminate consisting of an intermediate layer made of an aromatic polyamide resin with a heat shrinkage rate of less than 4%, and an outer layer having a higher melting point than the inner layer, and has an average shrinkage of 4.8 cc/m 2 after autoclave sterilization. Atmospheric pressure/
A material with an oxygen permeability of 20°C and 65% relative humidity or less is used. The outer layer is made of polyester film coated with vinylidene chloride resin, the intermediate layer is made of biaxially stretched aromatic nylon film, and the inner layer is made of unstretched polypropylene film. [Example] Hereinafter, the present invention will be described in more detail with reference to the accompanying drawings. As shown in FIG. 1, a medical article containing a liquid, particularly a plastic container 11 containing a drug solution 13, is
It is packaged in a package 14 made of the packaging material of this invention. The container 11 is made of a flexible plastic such as polyvinyl chloride resin or crosslinked ethylene-vinyl acetate copolymer. A port 12 communicating with the inside of the container 11 is provided at one end of the container 11, and a drug solution 13 containing components that are easily degraded by oxygen, particularly a high concentration (10 to 12% by weight) containing tryptophan, is provided at one end of the container 11.
Amino acid infusions, fat emulsions, vitamin preparations, etc. are introduced into the container 11 through the port 12. After introducing the chemical solution 13 into the container 11, the port 12 is sealed with a suitable sealing member by high frequency welding or the like. A plastic container 11 containing a drug solution is a packaging body 1.
4. It is preferable that the product is vacuum packaged. By vacuum packaging, the amount of oxygen present between the package 14 and the container 11 can be minimized, oxygen can be prevented from entering the chemical solution 13, and almost no air phase is present. As a result, thermal conductivity is improved and autoclave sterilization can be performed more efficiently. The packaging body 14 for packaging the plastic container 11 containing the drug solution is preferably transparent so that the state of the drug solution can be visually observed, and as shown in FIG. Consists of a laminate. The inner layer 21 has heat resistance (does not deform) to withstand the heat during autoclave sterilization, which will be described later, and has heat sealability since it is heat sealed. In addition, this inner layer 21
It is preferable that the material also has good moisture permeability. As the plastic material constituting such inner layer 21, unstretched polypropylene is particularly preferred. High-density polyethylene is also considered as the inner layer material, but it has a problem with transparency. In addition, the inner layer 21 is 60~
Preferably it has a thickness of 80 μm. The intermediate layer 22 has a heat shrinkage rate at 121°C (121°C
x30 minutes in saturated steam) is less than 4% biaxially oriented aromatic nylon film. Heat shrinkage rate is 4
%, the inner layer 21 and outer layer 23 will peel or wrinkle. Transparency also decreases. This intermediate layer 22 preferably has good gas (particularly oxygen gas) barrier properties, as well as excellent mechanical strength and moisture permeability. As the material constituting the intermediate layer 22, a biaxially stretched nylon film is particularly preferred. In addition to biaxially oriented aromatic nylon film, there are other materials with excellent gas barrier properties, such as vinylidene chloride resin and saponified ethylene-vinyl acetate copolymer, but they have poor heat resistance and water resistance, so they are not used as the intermediate layer 22. is inappropriate. In addition,
Preferably, the intermediate layer 22 has a thickness of 10 to 20 μm. The outer layer 23 is the part most susceptible to heat during autoclave sterilization, and needs to have a higher melting point than the inner layer 21. In addition, the outer layer 23
Desirably, the material also has good gas barrier properties and moisture permeability. The plastic material constituting the outer layer 23 is a vinylidene chloride resin coated on the inner surface to a thickness of 1 to 3 μm (so-called K
Coated polyester films are particularly preferred. Note that the outer layer 23 preferably has a thickness of 7 to 17 μm. The inner layers of the package 14 are heat-sealed together at the peripheral edge 14a (FIG. 1). In this way, the plastic container 11 containing the drug solution packaged in the package 14 is autoclaved in an atmosphere of saturated steam substantially free of oxygen while being packaged in the package 14. High pressure steam sterilization (autoclave sterilization) is usually performed at 121℃.
It is performed for 20 to 30 minutes. At this time, the package 1
In No. 4, there is almost no decrease in transparency, and there is also little decrease in gas barrier properties. Even after such autoclave sterilization, the package 14 is JIS compliant.
According to the standard, the overall average is 4.8cc/ m2・atmospheric pressure・24 hours・
Atmospheric pressure, 20℃, 65% relative humidity or less, preferably 3.0
cc/ m2 , 24 hours, atmospheric pressure, 20℃, 65% relative humidity or less, preferably 2.5cc/ m2 , 24 hours, atmospheric pressure, 20
It has an oxygen permeability of less than 65% relative humidity at °C. Below, vibration tests, coloring level tests, head space oxygen concentration tests, dissolved oxygen concentration tests, drug solution PH tests,
The results of the tryptophan content test are shown together with those of comparative examples. Vibration Test Plastic containers containing amino acid preparations containing tryptophan as medicinal solutions were each packaged with packaging materials having the following configurations. Invention: Inner layer: unstretched polypropylene film with a thickness of 70 μm Intermediate layer: biaxially stretched nylon film with a thickness of 15 μm Outer layer: polyester film with a thickness of 12 μm coated with K (1 to 3 μm) Comparative example: Inner layer: Thickness 60 μm polyethylene film Middle layer: 15 μm thick polyvinylidene chloride film Outer layer: 15 μm thick nylon film Each of the above samples was tested using a packaging cargo vibration tester according to JISZ0232.
Based on the vibration test method, a 5G x 1 hour vibration test was conducted to observe the occurrence of pinholes in the packaging material. Table 1 below shows the number of samples in which pinholes occurred for each 20 samples.

【表】 この結果から、この発明の包装材料は、過酷な
振動試験においてもピンホールが発生しないこと
がわかる。 着色レベル試験、ヘツドスペース酸素濃度試
験、溶存酸素濃度試験、薬液のPH試験、トリプ
トフアン含量試験 上記振動試験における本発明品を121℃で30分
間の高圧蒸気滅菌に供した後、60℃の恒温槽内に
放置し、0日、4日、8日、17日、30日経過後の
着色レベル(波長420nmにおける透過率T%を測
定)、ヘツドスペース酸素濃度(ヘツドスペース
部分の酸素濃度を酸素分析計で測定)、薬液(ア
ミノ酸製剤)のPH(PH計で測定)、アミノ酸製剤
中のトリプトフアン含量(アミノ酸分析計で測
定)を測定した。比較として、同様のアミノ酸製
剤入りスプラスチツク製容器をポリプロピレンフ
イルムで包装して同様の高圧蒸気滅菌に供した
後、上記振動試験における比較例の包装材料で包
装したものについて同様の試験をおこなつた。結
果をそれぞれ第3図〜第7図に示す。第3図〜第
7図において線aは本発明のもの、線bは比較例
のものである。この結果から、加速した着色レベ
ル試験、ヘツドスペース酸素濃度試験、溶存酸素
濃度試験、薬液のPH試験、トリプトフアン含量試
験において本発明品は比較例と同等あるいはそれ
以上であることがわかる。 酸素透過度および透湿度試験 上記振動試験の本発明品に用いた包装材料の高
圧蒸気滅菌(121℃x30分)前後における酸素透
過度および透湿度をASTM D3985−81に準じて
測定した。結果を以下の表2に示す。
[Table] From this result, it can be seen that the packaging material of the present invention does not generate pinholes even in severe vibration tests. Coloring level test, headspace oxygen concentration test, dissolved oxygen concentration test, chemical solution PH test, tryptophan content test The product of the present invention in the above vibration test was subjected to high-pressure steam sterilization at 121°C for 30 minutes, and then sterilized in a constant temperature bath at 60°C. After 0 days, 4 days, 8 days, 17 days, and 30 days, the coloring level (transmittance T% at a wavelength of 420 nm was measured), the head space oxygen concentration (the oxygen concentration in the head space was measured using an oxygen analyzer) The pH of the drug solution (amino acid preparation) (measured with a PH meter), and the tryptophan content in the amino acid preparation (measured with an amino acid analyzer) were measured. For comparison, a similar Splastic container containing an amino acid preparation was wrapped in polypropylene film and subjected to the same high-pressure steam sterilization, and then a similar test was conducted on a container packaged with the packaging material of the comparative example used in the vibration test. . The results are shown in FIGS. 3 to 7, respectively. In FIGS. 3 to 7, line a is for the present invention, and line b is for the comparative example. From these results, it can be seen that the products of the present invention are equivalent to or better than the comparative examples in the accelerated coloring level test, headspace oxygen concentration test, dissolved oxygen concentration test, chemical solution PH test, and tryptophan content test. Oxygen permeability and moisture permeability test The oxygen permeability and moisture permeability of the packaging material used for the product of the present invention in the vibration test above were measured before and after high-pressure steam sterilization (121°C x 30 minutes) according to ASTM D3985-81. The results are shown in Table 2 below.

【表】 [発明の効果] 以上述べたように、この発明によれば、一重包
装で、オートクレーブ滅菌に耐え得る耐熱性を有
するとともに、耐衝撃性およびガスバリヤー性に
優れた医療用物品包装体および包装材料が提供さ
れる。
[Table] [Effects of the Invention] As described above, according to the present invention, there is provided a medical article package that is single-packed, has heat resistance that can withstand autoclave sterilization, and has excellent impact resistance and gas barrier properties. and packaging materials are provided.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、この発明の医療用物品包装体を示す
平面図、第2図は、この発明の包装材料の断面
図、第3図ないし第7図は、この発明の医療用物
品包装体の特性を比較例とともに示すグラフ図。 11……プラスチツク製容器、13……薬液、
14……包装体、21……内層、22……中間
層、23……外層。
FIG. 1 is a plan view showing a medical article package of the present invention, FIG. 2 is a sectional view of the packaging material of the present invention, and FIGS. 3 to 7 are views of the medical article package of the present invention. Graph diagram showing characteristics together with comparative examples. 11...Plastic container, 13...Medicinal solution,
14... Packaging body, 21... Inner layer, 22... Intermediate layer, 23... Outer layer.

Claims (1)

【特許請求の範囲】 1 液体を収容した医療用物品と、透明な可撓性
材料からなり該医療用物品を包装する包装体を備
えた医療用物品包装体において、該包装体は、耐
熱性を有し熱シール性を有する未延伸ポリプロピ
レンフイルムからなる内層と、121℃における熱
収縮率が4%未満である二軸延伸芳香族ナイロン
フイルムからなる中間層と、該内層よりも高い融
点を有し、塩化ビニリデン樹脂をコートしたポリ
エステルフイルムからなる外層との積層体からな
り、オートクレーブ滅菌後において平均で3.0
c.c./m2・24時間・気圧・20℃・65%相対湿度以下
の酸素透過度を有することを特徴とする医療用物
品包装体。 2 医療用物品が、ビタミン製剤、脂肪乳剤また
はアミノ酸製剤を収容したプラスチツク製容器で
ある特許請求の範囲第1項記載の医療用物品包装
体。 3 医療用物品が、包装体内に真空包装されてい
る特許請求の範囲第1項または第2項記載の医療
用物品包装体。 4 液体を収容した医療用物品を包装するための
包装材料において、耐熱性を有し熱シール性を有
する未延伸ポリプロピレンフイルムからなる内層
と、121℃における熱収縮率が4%未満である二
軸延伸芳香族ナイロンフイルムからなる中間層
と、該内層よりも高い融点を有し、塩化ビニリデ
ン樹脂をコートしたポリエステルフイルムからな
る外層との積層体からなり、オートクレーブ滅菌
後において平均で3.0c.c./m2・24時間・気圧・20
℃・65%相対湿度以下の酸素透過度を有すること
を特徴とする包装材料。
[Scope of Claims] 1. A medical article package comprising a medical article containing a liquid and a package made of a transparent flexible material for packaging the medical article, wherein the package is heat-resistant. an inner layer made of an unstretched polypropylene film having heat-sealing properties, an intermediate layer made of a biaxially oriented aromatic nylon film having a heat shrinkage rate of less than 4% at 121°C, and a melting point higher than that of the inner layer. It is made of a laminate with an outer layer made of polyester film coated with vinylidene chloride resin, and has an average resistance of 3.0 after autoclave sterilization.
A medical article packaging body characterized by having an oxygen permeability of cc/m 2 / 24 hours / atmospheric pressure / 20°C / 65% relative humidity or less. 2. The medical article package according to claim 1, wherein the medical article is a plastic container containing a vitamin preparation, a fat emulsion, or an amino acid preparation. 3. The medical article package according to claim 1 or 2, wherein the medical article is vacuum packaged within the package. 4. Packaging materials for packaging medical articles containing liquids, including an inner layer made of an unstretched polypropylene film that is heat resistant and has heat sealability, and a biaxial material with a heat shrinkage rate of less than 4% at 121°C. It consists of a laminate consisting of an intermediate layer made of a stretched aromatic nylon film and an outer layer made of a polyester film coated with vinylidene chloride resin, which has a higher melting point than the inner layer, and has an average of 3.0 cc/m 2 after autoclave sterilization.・24 hours・Atmospheric pressure・20
A packaging material characterized by having an oxygen permeability of 65% relative humidity or less at °C.
JP61315582A 1986-12-26 1986-12-26 Medical article package and packing material Granted JPS63164950A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61315582A JPS63164950A (en) 1986-12-26 1986-12-26 Medical article package and packing material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61315582A JPS63164950A (en) 1986-12-26 1986-12-26 Medical article package and packing material

Publications (2)

Publication Number Publication Date
JPS63164950A JPS63164950A (en) 1988-07-08
JPH031021B2 true JPH031021B2 (en) 1991-01-09

Family

ID=18067085

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61315582A Granted JPS63164950A (en) 1986-12-26 1986-12-26 Medical article package and packing material

Country Status (1)

Country Link
JP (1) JPS63164950A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH063602Y2 (en) * 1988-11-16 1994-02-02 大日本印刷株式会社 Medical packaging
JP2005040489A (en) * 2003-07-25 2005-02-17 Fuji Seal International Inc Transfusion bag and its package
JP4828281B2 (en) * 2005-06-03 2011-11-30 株式会社クラレ Vacuum packaging bag

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5980256A (en) * 1982-10-30 1984-05-09 テルモ株式会社 Plastic container filled with drug generating no deterioration for long period time
JPS59174352A (en) * 1983-03-22 1984-10-02 昭和アルミニウム株式会社 Packing material for retort food

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5980256A (en) * 1982-10-30 1984-05-09 テルモ株式会社 Plastic container filled with drug generating no deterioration for long period time
JPS59174352A (en) * 1983-03-22 1984-10-02 昭和アルミニウム株式会社 Packing material for retort food

Also Published As

Publication number Publication date
JPS63164950A (en) 1988-07-08

Similar Documents

Publication Publication Date Title
US5763028A (en) Doubly-packaged easily oxidizable article
EP0109983B1 (en) Method for manufacturing plastic container containing infusion solution which does not allow deterioration of infusion solution for long period of time
US4654240A (en) Laminate film for flexible containers
US4421823A (en) Flexible wrapping material and method of manufacture
EP0619178B1 (en) Process for producing multilayered film materials
EP0686091B1 (en) Autoclavable multilayer films
JPH02180129A (en) Oxygen isolation retort pouch
JPH0518709B2 (en)
JPH031021B2 (en)
JP2837435B2 (en) Infusion bag
JP2906487B2 (en) Medical article transparent package
JP2825898B2 (en) Laminated film for packaging
JPH0428368A (en) Enclosing body of medicine containing l-menthol
JP2837434B2 (en) Infusion bag
JPH0380509B2 (en)
JPH0631880A (en) Laminated film for pressurization heating sterilization wrapping
JPH07100185A (en) Container for medical liquid
JP2019026307A (en) Standing pouch
JPH0532282Y2 (en)
JP3455809B2 (en) Outer packaging bag for storing and storing chemical solution bags
JP2008213903A (en) Laminated packaging material and outer package bag
JPH0396346A (en) Heat resistant heat sealable packaging material
JPH07171197A (en) Packing bag for medical container
JPH07291301A (en) Packaging bag for container for medical application
JPH07171196A (en) Packing bag for medical container

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term